Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Theravance Biopharma
Business Segments
Geographic
Revenue
Revenue
Theravance Biopharma
·
Geographic
·
2 segments
·
Rolls up to
Total Revenue
Breakdown
Segments
Europe
View metric
US
View metric
Annual
Segment
FY'21
FY'22
FY'23
FY'24
FY'25
US
$55.27M
$51.12M
$57.2M
$64.38M
$74.96M
Europe
$38K
$222K
$223K
—
$32.5M
Total
$55.31M
$51.35M
$57.42M
$64.38M
$107.46M
All segment values are derived from annual filings.